Abstract
l-3,4-dihydroxyphenylalanine (l-DOPA) is an effective treatment for Parkinson9s disease (PD); however, long-term treatment induces l-DOPA-induced dyskinesia (LID). To elucidate its pathophysiology, we developed a mouse model of LID by daily...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have